Specialty code 1835P0018X · Wilmington, NC
NPI
1396362778
Since 2020
Specialty
Specialty code 1835P0018X
Code 1835P0018X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2131 S 17th St
Wilmington, NC, 28401
Phone (910) 667-7000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$5.5M
2,242 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Cori J Shope prescribed most often to Medicare patients was Rytary (Carbidopa/Levodopa), with 193 prescriptions and refills. In total Cori J Shope wrote 2,242 Medicare prescriptions that cost $5.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rytary Carbidopa/Levodopa | 193 | 242 | 28 | $276K |
| Ubrelvy Ubrogepant | 150 | 156 | 35 | $167K |
| Aimovig Autoinjector Erenumab-Aooe | 128 | 148 | 31 | $106K |
| Radicava Ors Edaravone | 123 | 128 | 21 | $1.7M |
| Nurtec Odt Rimegepant Sulfate | 117 | 122 | 29 | $187K |
| Emgality Pen Galcanezumab-Gnlm | 96 | 106 | 25 | $71K |
| Eliquis Apixaban | 79 | 213 | 26 | $117K |
| Riluzole Generic | 79 | 102 | 15 | $23K |
| Rivastigmine Generic | 71 | 101 | 18 | $12K |
| Brilinta Ticagrelor | 53 | 121 | 15 | $50K |
| Neupro Rotigotine | 52 | 78 | 12 | $62K |
| Kesimpta Pen Ofatumumab | 36 | 36 | Under 11 | $383K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 33 | 76 | 12 | $5,560 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 31 | 54 | Under 11 | $859 |
| Trazodone Hcl Generic | 30 | 32 | Under 11 | $266 |
Brand drugs: 1,440 claims; generic drugs: - claims; opioid claims: 28.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Cori J Shope were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.